BSX
$25.59
Boston Scientific
$.09
.35%
BSX
Earnings Whisper ®
N/A
4th Quarter December 2017
Consensus:  $0.34
Revenue:  $2.35 Bil
Thursday
Jan 25
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, October 26, 2017

What do you expect when BSX reports earnings?
Beat
Meet
Miss

Where is BSX's stock price going from here?
Up
Flat
Down
Stock chart of BSX
Analysts
Summary of analysts' recommendations for BSX
Score
Grade
Pivots
Resistance
$25.96
$25.87
$25.68

$25.59

Support
$25.40
$25.31
$25.12
Tweet
Growth
Description
Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.
Peers
Abbott LaboratoriesStrykerBecton, DickinsonC. R. BardBaxter InternationalWatersIntegra LifeSciences Holdings3MResMedAbiomed